Rekombinanter Frataxin Antikörper (AA 57-210)
Kurzübersicht für Rekombinanter Frataxin Antikörper (AA 57-210) (ABIN6939443)
Target
Alle Frataxin (FXN) Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 57-210
-
Aufreinigung
- Purified by Protein A/G
-
Immunogen
- Recombinant human Frataxin protein fragment (around aa 57-210) (exact sequence is proprietary)
-
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Positive Control: HepG2, HL-60 or HEK293 cells. Pancreas and Liver.
Known Application: ELISA (Use Ab at 2-4 μg/mL for coating) (Order Ab without BSA),Optimal dilution for a specific application should be determined.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 200 μg/mL
-
Buffer
- 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-80 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Haltbarkeit
- 24 months
-
-
- Frataxin (FXN)
-
Andere Bezeichnung
- FXN
-
Hintergrund
- Frataxin is a nuclear-encoded mitochondrial protein implicated in Friedreich's ataxia (FRDA), a human autosomal recessive neurodegenerative disease. Lack of Frataxin causes iron to accumulate in the mitochondrial matrix suggesting that Frataxin is involved in mitochondrial iron homeostasis and possibly in iron transport. Frataxin has an alpha-beta fold consisting of two helices flanking an antiparallel beta sheet.
-
Molekulargewicht
- 14kDa
-
Gen-ID
- 2395
-
UniProt
- Q16595
-
Pathways
- Transition Metal Ion Homeostasis, Regulation of Cell Size
Target
-